Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term follow-up of preterm children previously enrolled in ROPP-2008-01
NL-OMON42024Phase 2Active, not recruiting
- Sponsor
- Takeda
- Start
- Sep 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Premiplex in retinopathy of prematurity (ROP) (2 arms), sponsored by Takeda. Started Sep 2015; status: active, not recruiting.
02
Drugs
Premiplex
03
Conditions
retinopathy of prematurity (ROP)
Beyond the preview
Go deeper on NL-OMON42024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42024.